Autoreactive cells in cancer-active immunotherapy: their cytotoxic potential and genetic restriction.
D000406:AKR murine leukemia virus / Q000276:immunology; D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology*; D001500:BCG Vaccine / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D003602:Cytotoxicity, Immunologic; D006086:Graft vs Host Disease / Q000276:immunology; D006183:H-2 Antigens; D007942:Leukemia, Experimental / Q000628:therapy*; D008175:Lung Neoplasms / Q000628:therapy*; D051379:Mice; D008806:Mice, Inbred AKR / Q000235:genetics*; D008810:Mice, Inbred C57BL / Q000235:genetics*; D051381:Rats
D001500:BCG Vaccine; D006183:H-2 Antigens